who should not use glp-1 Medications: Everything You Need to Know GLP-1 Safety: Who Shouldn't Use

2015 Summer;45(4):426-32

CJC-1295 and Ipamorelin are studied for potential support in muscle protein synthesis, enhanced post-training recovery, lean muscle development, improved body composition, and athletic performance optimization through growth hormone pathway support

Additionally, they confer multiple cardiovascular benefits, including reducing the risk of hypertension and coronary heart disease, known comorbidities of COPD [51]

For patients with diabetes, withholding GLP-1 therapy may require temporary adjustment of other glucose-lowering medications

Further studies revealed that the deprivation of Gln induced iron death in liver tumor cells and heightened their radiosensitivity, while Gln supplementation completely reversed the effects of iron death